Category: Biomarkers
Global Biomarkers
-
Digital Biomarkers Market - Global Outlook & Forecast 2024-2029
... 2029. MARKET TRENDS & DRIVERS Rise in Digitized Virtual Clinical Research The rise in digitized virtual clinical research is a significant trend in the global digital biomarkers market, driven by advances in remote monitoring technologies ... Read More
-
Global AI in Cancer Diagnostics Market (2023-2028) by Components, Cancer Type, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
... 147.61 Mn in 2023 and is expected to reach USD 400.91 Mn by 2028 growing at a CAGR of 22.12%. Market dynamics, which refers to the ever-changing and evolving conditions, trends, and forces that impact ... Read More
-
Global Cancer Profiling Market Assessment, By Biomarker Type [Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers], By Technology [Immunoassays, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Microarray, Spectroscopic Method, Others], By Cancer Type [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Other Cancer], By Application [Clinical Application, Research Application], By End-user [Hospital Associated Diagnostic Laboratories, Diagnostic Centers, Cancer Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
... Cancer Type [Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Other Cancer], By Application [Clinical Application, Research Application], By End-user [Hospital Associated Diagnostic Laboratories, Diagnostic Centers, ... Read More
-
Clinical Biomarkers Market - A Global and Regional Analysis: Focus on Offering, Clinical Area, Technology, End User, and Region - Analysis and Forecast, 2023-2033
... valued at $24.80 billion in 2023 and is expected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% between 2023 and 2033. The term clinical biomarkers refers to the quantifiable biological parameter ... Read More
-
Global Epigenetics Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Cardiac Biomarkers Market Forecasts to 2030 – Global Analysis By Product Type (B-Type Natriuretic Peptide (BNP), Creatine Kinase-Muscle/Brain (CK-MB) and Other Product Types), By Location of Testing (Point-of-care Testing and Laboratory Testing), Application, End User and By Geography
... and By Geography According to Stratistics MRC, the Global Cardiac Biomarkers Market is accounted for $18.7 billion in 2023 and is expected to reach $54.8 billion by 2030 growing at a CAGR of 16.6% during ... Read More
-
Global Europium Nanoparticle in Biological Sector Sales Market Report 2024
... million by 2030 with a CAGR of 9.03% during the forecast period 2024-2030. The global key players of Europium Nanoparticle in Biological Sector include Thermo Fisher Scientific, Merck, Suzhou NanoMicro Technology Co, Bangs Laboratories, Inc. ... Read More
-
Cancer Biomarker Global Market Report 2024
... Cancer; Thyroid Cancer; Kidney Cancer4) By Application: Diagnostics; Research And Development; Prognostics; Risk AssessmentCovering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; QIAGEN NV; Illumina Inc.; Bio-Rad Laboratories Inc. Cancer Biomarker Global Market Report 2024 ... Read More
-
Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028
... projected to reach USD 4.3 billion by 2028 from USD 2.1 billion in 2023, at a CAGR of 15.5% from 2023 to 2028. Factors such as rising baby boomer population and advances in research and ... Read More
-
Speech Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
... markets. The global speech biomarker market is expected to reach an estimated $1.49 billion by 2030 with a CAGR of 16.7% from 2024 to 2030. The major drivers for this market are increasing prevalence of ... Read More
-
Biomarkers Market Size, Share & Trends Analysis Report By Type (Efficacy, Validation), By Product, By Application (Drug Discovery & Development, Personalized Medicine), By Disease, By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global biomarkers market size is expected to reach USD 194.21 billion by 2030, registering a CAGR of 13.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028
... to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period. The growth of this market can be attributed to the increasing ... Read More
-
Neurological Biomarkers Market by Type (Genomic, Imaging, Metabolomic), Application (Alzheimer’s Disease, Autism Spectrum Disorders, Multiple Sclerosis), End-user - Global Forecast 2024-2030
... expected to reach USD 10.24 billion in 2024, at a CAGR 14.05% to reach USD 22.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Neurological Biomarkers Market. It ... Read More
-
Renal Biomarkers Market by Marker Type (Blood Urea Nitrogen, Creatinine, Cystatin C), Assay Platform Type (Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Turbidimetric Immunoassay), Application, End-User - Global Forecast 2024-2030
... estimated at USD 1.33 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 7.72% to reach USD 2.24 billion by 2030. Global Renal Biomarkers Market FPNV Positioning Matrix The ... Read More
-
Cardiac Biomarker Market by Type (Brain Natriuretic Peptide or NT-proBNP, Creatine Kinase, Ischemia Modified Albumin), Location of Testing (Laboratory Testing, Point of Care Testing), Application - Global Forecast 2024-2030
... estimated at USD 4.62 billion in 2023 and expected to reach USD 5.31 billion in 2024, at a CAGR 14.90% to reach USD 12.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Central Lab Market by Services (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), End-Use (Academic & Research Institutes, Biotechnology Companies, Pharmaceutical Companies) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 3.23 billion in 2024, at a CAGR 8.19% to reach USD 5.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Liquid Biopsy Market by Biomarkers (Cell-free DNA, Circulating Tumor Cells, Circulating Tumor DNA), Sample (Blood Based, Urine Based), Type, Technology, Indication, End-User, Application - Global Forecast 2024-2030
... USD 1.70 billion in 2023 and expected to reach USD 2.05 billion in 2024, at a CAGR 20.39% to reach USD 6.25 billion by 2030. Global Liquid Biopsy Market Liquid biopsy has emerged as an ... Read More
-
Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Global Forecast 2024-2030
... Testing Devices Market size was estimated at USD 858.76 million in 2023 and expected to reach USD 1,023.60 million in 2024, at a CAGR 19.59% to reach USD 3,004.57 million by 2030. Global Breast Cancer ... Read More
-
Bioanalytical Testing Services Market by Type (Biomarker Testing, Cell-Based Assays, Method Development Optimization & Validation), Application (Cardiology, Gastroenterology, Infectious Diseases), End User - Global Forecast 2024-2030
... USD 4.33 billion in 2023 and expected to reach USD 4.74 billion in 2024, at a CAGR 9.63% to reach USD 8.24 billion by 2030. Global Bioanalytical Testing Services Market FPNV Positioning Matrix The FPNV ... Read More
-
Digital Biomarkers Market by Type (Hardware, Software), Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Musculoskeletal disorders, Neurological disorders), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.34 billion in 2024, at a CAGR 19.97% to reach USD 13.00 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital Biomarkers ... Read More
-
Ice Flaker Machines Market by Services (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), End-Use (Academic & Research Institutes, Biotechnology Companies, Pharmaceutical Companies) - Global Forecast 2024-2030
... 1.52 billion in 2023 and expected to reach USD 1.61 billion in 2024, at a CAGR 6.43% to reach USD 2.36 billion by 2030. Global Ice Flaker Machines Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Oncology Based In-Vivo CRO Market by Services (Biomarker Development, Clinical Trial Management, Pharmacokinetics Studies), Indication (Hematological Malignancies, Rare Cancer, Solid Tumor), End-User - Global Forecast 2024-2030
... at USD 1.27 billion in 2023 and expected to reach USD 1.41 billion in 2024, at a CAGR 11.34% to reach USD 2.70 billion by 2030. Global Oncology Based In-Vivo CRO Market FPNV Positioning Matrix ... Read More
-
Label-free Array System Market by Technique (Atomic Force Microscopy, Ellipsometry Techniques, Enthalpy Array), Application (Biomolecular Interactions, Detection of Disease Biomarkers, Drug Discovery), End User - Global Forecast 2024-2030
... estimated at USD 1.38 billion in 2023 and expected to reach USD 1.49 billion in 2024, at a CAGR 8.11% to reach USD 2.38 billion by 2030. Global Label-free Array System Market FPNV Positioning Matrix ... Read More
-
Breast Cancer Liquid Biopsy Market by Biomarker (Cell-free DNA, Circulating Tumor Cells, Extracellular Vesicles), End-User (Hospitals & Physician Laboratories, Reference Laboratories) - Global Forecast 2024-2030
... USD 494.29 million in 2023 and expected to reach USD 589.92 million in 2024, at a CAGR 19.44% to reach USD 1,714.15 million by 2030. Global Breast Cancer Liquid Biopsy Market FPNV Positioning Matrix The ... Read More
-
Rare Biomarkers Specimen Collection & Stabilization Market by Product Type (Circulating Cell Free DNA, Circulating Tumor Cells, Exosomes or Extracellular Vesicles), Collection Type (Blood Collection Tubes & Systems, Isolation Kits & Reagents), Application
... - Global Forecast 2024-2030 The Rare Biomarkers Specimen Collection & Stabilization Market size was estimated at USD 29.94 billion in 2023 and expected to reach USD 32.21 billion in 2024, at a CAGR 7.54% to ... Read More
Research Assistance
